SynNeogen® is the world's first engineered murine Fc chimeric protein vaccine platform, powered by the dual engines of AI-driven antigen selection and Fc-mediated precision delivery. The platform leverages AI to identify tumor- or virus-specific T-cell epitopes, and integrates engineered heterologous Fc with glyco-engineering modifications. This design mimics natural immune processes by enabling Fc-mediated, dendritic cell (DC)-targeted delivery of antigens, thereby inducing durable, multi-epitope T-cell responses.